Systemic Effects of A Continuous Blood Flow Restricted Aerobic Exercise Session in COPD Patients: A Randomised Controlled Trial.
1 other identifier
interventional
46
1 country
1
Brief Summary
Patients with COPD that a pulmonologist classifies between Stage 1-2 in accordance with the GOLD criteria and age and gender-matched healthy individuals will be included in the study. In both groups (n = COPD: 17, Healthy: 17), aerobic exercise (AE) in the target heart rate range of 50% intensity, performed by cycling accompanied by blood flow restriction, will be applied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 17, 2020
CompletedFirst Submitted
Initial submission to the registry
August 18, 2020
CompletedFirst Posted
Study publicly available on registry
August 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2024
CompletedMarch 20, 2024
March 1, 2024
3.6 years
August 18, 2020
March 19, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
creatine kinase
rhabdomyolysis marker
30 minutes
C reactive protein, neutrophil
inflammatory marker
30 minutes
oxygen saturation
blood oxygen saturation
30 minutes
heart rate
determination of aerobic exercise dose
30 minutes
systolic and diastolic pressure
to mean arterial pressure calculation
up to 18 weeks
modified borg scale
dyspnoea measurement, Minimum 1, maximum 7 points are obtained. 5 indicates the best respiratory condition, 10 the worst respiratory condition.
up to 18 weeks.
oxidative stress markers
uric acid, lactate dehydrogenase
up to 18 weeks
Study Arms (2)
healthy group
ACTIVE COMPARATOR25 healthy individuals between the ages of 40-70 will be contacted by phone and included in the initiative.
patient group
ACTIVE COMPARATOR25 individuals will be selected randomly from 103 patients with COPD from hospital records.
Interventions
Patients and healthy individuals will be given 30 minutes of aerobic exercise by cycling, by restricting lower extremity blood flow.
Eligibility Criteria
You may qualify if:
- No drug change for at least 30 days for the COPD group
- Not participating in a structured activity program for at least six months
- Have the ability to cooperate
You may not qualify if:
- Presence of any pathology that limits physical activity performance
- Presence of severe or unstable heart disease
- Presence of peripheral artery disease
- Being in an exacerbation period of the disease
- Presence of another active disease (rheumatic, oncological, traumatic etc.)
- Any neurological or orthopedic disease that prevents exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karabük Üniversitesi Araştırma Hastanesi Göğüs Hastalıkları Kliniği
Karabük, 78600, Turkey (Türkiye)
Related Publications (7)
Patterson SD, Hughes L, Warmington S, Burr J, Scott BR, Owens J, Abe T, Nielsen JL, Libardi CA, Laurentino G, Neto GR, Brandner C, Martin-Hernandez J, Loenneke J. Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety. Front Physiol. 2019 May 15;10:533. doi: 10.3389/fphys.2019.00533. eCollection 2019.
PMID: 31156448RESULTKacin A, Strazar K. Frequent low-load ischemic resistance exercise to failure enhances muscle oxygen delivery and endurance capacity. Scand J Med Sci Sports. 2011 Dec;21(6):e231-41. doi: 10.1111/j.1600-0838.2010.01260.x. Epub 2011 Mar 8.
PMID: 21385216RESULTScott BR, Loenneke JP, Slattery KM, Dascombe BJ. Exercise with blood flow restriction: an updated evidence-based approach for enhanced muscular development. Sports Med. 2015 Mar;45(3):313-25. doi: 10.1007/s40279-014-0288-1.
PMID: 25430600RESULTNolan CM, Rochester CL. Exercise Training Modalities for People with Chronic Obstructive Pulmonary Disease. COPD. 2019 Dec;16(5-6):378-389. doi: 10.1080/15412555.2019.1637834. Epub 2019 Nov 4.
PMID: 31684769RESULTLoenneke JP, Allen KM, Mouser JG, Thiebaud RS, Kim D, Abe T, Bemben MG. Blood flow restriction in the upper and lower limbs is predicted by limb circumference and systolic blood pressure. Eur J Appl Physiol. 2015 Feb;115(2):397-405. doi: 10.1007/s00421-014-3030-7. Epub 2014 Oct 22.
PMID: 25338316RESULTWilson JM, Lowery RP, Joy JM, Loenneke JP, Naimo MA. Practical blood flow restriction training increases acute determinants of hypertrophy without increasing indices of muscle damage. J Strength Cond Res. 2013 Nov;27(11):3068-75. doi: 10.1519/JSC.0b013e31828a1ffa.
PMID: 23446173RESULTBerzosa C, Cebrian I, Fuentes-Broto L, Gomez-Trullen E, Piedrafita E, Martinez-Ballarin E, Lopez-Pingarron L, Reiter RJ, Garcia JJ. Acute exercise increases plasma total antioxidant status and antioxidant enzyme activities in untrained men. J Biomed Biotechnol. 2011;2011:540458. doi: 10.1155/2011/540458. Epub 2011 Mar 9.
PMID: 21436993RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- 25 COPD patients were referred to the study from the pulmonology clinic of the hospital where the study was conducted by a medical secretary who was blinded to the intervention. In addition, 21 healthy individuals volunteered to participate in the study from the same hospital where the study was previously announced.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
August 18, 2020
First Posted
August 25, 2020
Study Start
August 17, 2020
Primary Completion
March 19, 2024
Study Completion
April 15, 2024
Last Updated
March 20, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share